XORTX Therapeutics Inc.
XRTX
$2.28
-$0.03-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.69M | -808.50K | -590.50K | -649.50K | -717.70K |
| Total Depreciation and Amortization | 18.30K | 25.80K | 29.10K | 29.40K | 27.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.20K | -6.10K | -88.00K | -65.50K | -169.30K |
| Change in Net Operating Assets | -1.61M | 287.40K | -52.50K | 56.00K | 65.80K |
| Cash from Operations | -3.27M | -501.40K | -701.90K | -629.60K | -793.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -139.50K | -7.90K | -264.30K | -5.50K | -21.80K |
| Cash from Investing | -139.50K | -7.90K | -264.30K | -5.50K | -21.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.10K | -22.20K | -21.80K | -21.40K | -23.30K |
| Issuance of Common Stock | 5.00M | -- | 1.10M | 1.04M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -827.70K | -82.00K | -448.20K | -247.20K | -20.20K |
| Cash from Financing | 4.16M | -104.20K | 632.50K | 770.90K | -43.40K |
| Foreign Exchange rate Adjustments | -6.40K | -800.00 | 4.20K | -5.30K | 27.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 743.80K | -614.20K | -329.40K | 130.40K | -831.80K |